Harigai R, Sato R, Hirose C, Takenouchi T, Kosaki K, Hirose T, et al. Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation. Cancers (Basel). 2022;14: pubmed publisher

McFall T, Stites E. Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach. Cell Rep. 2021;37:110096 pubmed publisher

Peta C, Tsirimonaki E, Samouil D, Georgiadou K, Mangoura D. Nuclear Isoforms of Neurofibromin Are Required for Proper Spindle Organization and Chromosome Segregation. Cells. 2020;9: pubmed publisher

Isakson S, Rizzardi A, Coutts A, Carlson D, Kirstein M, Fisher J, et al. Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. Commun Biol. 2018;1:158 pubmed publisher

Razavi P, Chang M, Xu G, Bandlamudi C, Ross D, VASAN N, et al. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. Cancer Cell. 2018;34:427-438.e6 pubmed publisher